Swedish Tobacco Stock News

Ferronordic stock has quietly turned into a comeback story. The share now trades at SEK81.6 after strong gains over the past quarter, and today’s Q2 print shows the recovery in the business is running ahead of where many investors had priced it in. The headline is simple. Ferronordic has swung back to solid profitability with Q2 net profit of SEK45m and basic earnings per share of 3.08 SEK, alongside SEK1.6b of revenue. With the stock on a reported P/E of 15.2x and trailing twelve month...

European markets have shown resilience recently, with the pan-European STOXX Europe 600 Index ending the week up by 1.70%, supported by firmer risk appetite and robust earnings despite ongoing geopolitical volatility. In this context, identifying stocks that may be trading below their estimated value can offer investors potential opportunities to capitalize on market conditions, especially when considering companies with strong fundamentals and growth prospects amidst such economic dynamics.

Peab stock reacts to new Nordic public sector contracts Peab (OM:PEAB B) has attracted fresh investor attention after securing two public sector projects in Finland and Norway worth a combined SEK 287 million, expanding its healthcare and education construction workload. See our latest analysis for Peab. These new public sector contracts arrive after a 30 day share price return of 8.42% and a year to date share price return of 9.55% for Peab. The 1 year total shareholder return stands at...

As European markets show resilience with the STOXX Europe 600 Index climbing and major indices like Germany's DAX and France's CAC 40 posting gains, investors are increasingly focusing on companies that combine growth potential with strong insider ownership. In such a climate, stocks where insiders hold significant stakes can be particularly appealing as they may align management interests with those of shareholders, potentially enhancing company performance amidst the current geopolitical...

The European market has recently seen a boost, with the STOXX Europe 600 Index rising by 1.70%, supported by resilient earnings and an improved risk appetite despite ongoing geopolitical uncertainties. In this context, penny stocks—often considered relics of past market eras—remain relevant as they represent potential growth opportunities at lower price points. Typically associated with smaller or newer companies, these stocks can offer significant upside when backed by strong financial...

As European markets continue to navigate a landscape of resilient earnings and fluctuating geopolitical tensions, the pan-European STOXX Europe 600 Index has shown promising gains, reflecting a firmer risk appetite among investors. In this dynamic environment, identifying stocks with strong fundamentals becomes crucial for those seeking potential opportunities amidst the market's complexities.

Paradox Interactive (OM:PDX) is back in focus after its 6 August 2026 earnings report, with Q2 sales of SEK 524 million and net income of SEK 149 million shaping how investors reassess the stock. See our latest analysis for Paradox Interactive. At a share price of SEK135.3, Paradox Interactive has seen a 1-day share price return of 1.96% and a 30-day share price return of 2.50%. However, the year-to-date share price return is down 13.88% and the 3-year total shareholder return has declined...

In recent weeks, European markets have shown resilience with the STOXX Europe 600 Index climbing steadily, buoyed by firm risk appetite and robust earnings despite a volatile geopolitical landscape. As investors navigate these dynamic conditions, identifying stocks with strong fundamentals and potential for growth becomes crucial in uncovering Europe's undiscovered gems.

Swedish Orphan Biovitrum has delivered a strong share price run over the past five years. However, its current market multiples screen as overvalued, and broader valuation checks point to a stock that is not obviously cheap. For investors, that mix raises the question of how much of the company’s recent progress and pipeline activity is already reflected in today’s price. Swedish Orphan Biovitrum has returned 155.5% over the past five years, which puts a clear spotlight on whether the...

In recent weeks, the European market has shown resilience, with the STOXX Europe 600 Index rising by 1.70% amid firmer risk appetite and solid earnings reports. Despite a volatile geopolitical backdrop, key indices like Germany's DAX and France's CAC 40 have posted significant gains, reflecting optimism about economic recovery and easing energy concerns. In this context, identifying small-cap stocks with strong fundamentals and insider activity can be particularly appealing to investors...

European equities have recently shown resilience, with the pan-European STOXX Europe 600 Index rising by 1.70% amid firmer risk appetite and robust earnings reports. In this context, penny stocks—often representing smaller or newer companies—remain a notable segment for investors seeking growth opportunities at lower price points. Despite being considered a somewhat outdated term, these stocks can offer potential upside when backed by strong financials and fundamentals, making them an...

Neem's Hill AB ( STO:NEEMS B ) is possibly approaching a major achievement in its business, so we would like to shine...

Atrium Ljungberg AB (publ) ( STO:ATRLJ B ), might not be a large cap stock, but it saw significant share price movement...

Anyone interested in Medicover AB (publ) ( STO:MCOV B ) should probably be aware that the General Legal Counsel, Jenny...

RVRC Holding just put investors through a sentiment stress test. The stock came into the report soft, down roughly 9% over the past week and 8% over the past month, even as the full year numbers told a sturdier story. Revenue landed at SEK 2,018m with a trailing net profit margin of 16.6%, and earnings per share over the last twelve months reached SEK 3.10. The real flashpoint for emotion is valuation. RVRC Holding still trades on a P/E of 18.1x, which keeps expectations high and reactions...

Storskogen Group stock closed at SEK10.82 today after a flat week and a strong 30 day run. Yet the real story sits inside the fresh Q2 print. The company delivered net sales of SEK8.86b and adjusted earnings before interest, tax and amortisation of SEK864m, with margin holding close to 10% despite a tougher backdrop in parts of Services and Trade. For you as an investor, the short term price action now meets a longer term question. Can this mix of organic growth, steady margins and a 3.4% net...

Clas Ohlson (OM:CLAS B) drew fresh attention after reporting July 2026/27 sales of SEK 1,164 million, with total May to July net sales of SEK 3,278 million and clear contributions from organic growth, acquisitions and currency. See our latest analysis for Clas Ohlson. The latest sales update lands after a strong run in Clas Ohlson’s share price, with a 7.51% 1 month share price return and a 43.28% year to date share price return. The 5 year total shareholder return of over 5x signals powerful...

In August 2026, European stock markets have shown resilience with the pan-European STOXX Europe 600 Index rising by 1.70%, buoyed by strong earnings and a firmer risk appetite despite ongoing geopolitical uncertainties. As investors navigate these conditions, identifying stocks that are potentially undervalued relative to their intrinsic value can offer opportunities for those looking to capitalize on resilient sectors and companies exhibiting robust fundamentals amidst a volatile market...

The European market has recently experienced a boost, with the pan-European STOXX Europe 600 Index rising by 1.70%, supported by resilient earnings and increased risk appetite despite ongoing geopolitical volatility. In this context, investors are keenly observing small-cap stocks, which often offer unique opportunities for growth due to their potential for agility and innovation in dynamic economic conditions.

European equities have recently been buoyed by a firmer risk appetite and resilient earnings, despite ongoing geopolitical volatility. As the pan-European STOXX Europe 600 Index sees gains, investors are increasingly looking for opportunities in stocks trading below their estimated fair value. Identifying undervalued stocks can be particularly appealing in such a market environment, where economic activity shows signs of recovery and investor sentiment remains cautiously optimistic.

As European markets experience a boost from resilient earnings and increased risk appetite, investors are keenly observing growth companies with high insider ownership. In this environment, stocks with strong insider commitment can offer insights into potential long-term value, aligning well with the current market's focus on stability amidst geopolitical volatility.

Hexagon (OM:HEXA B) released its second quarter 2026 results on 29 July, with sales reported at €1,050.2 million and a net loss of €1,266.1 million, compared with a net profit a year earlier. See our latest analysis for Hexagon. Hexagon's share price has risen 19.5% over the past month and 3.3% over the past quarter, yet it remains down 9.1% year to date. The 1 year total shareholder return of 10.3% and 3 year total shareholder return of 18.8% point to longer term gains that contrast with the...

The European market has recently shown signs of resilience, with the STOXX Europe 600 Index rising by 1.70%, bolstered by a stronger risk appetite and firm earnings despite ongoing geopolitical uncertainties. As investors navigate these dynamic conditions, identifying small-cap stocks that demonstrate strong fundamentals and potential for growth can be particularly appealing, especially when insider buying suggests confidence in their future prospects.

The European stock market has recently shown resilience with the STOXX Europe 600 Index gaining 1.70%, bolstered by robust earnings and a firmer risk appetite despite ongoing geopolitical volatility. In such an environment, identifying undervalued stocks can be particularly appealing, as they may offer potential opportunities for investors looking to capitalize on discrepancies between market prices and intrinsic values.